TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Average puncture time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean changes in TS scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: perceived confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: satisfaction with the learning experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: recurrence of lesions
Endpoint domain: Mortality/survival
Primary endpoint: reduction in lesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of culture-positive UTI
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative activity assessment scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight of cone specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of advanced neoplasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Detection of advanced distal neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Detection of advanced proximal neoplasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete visual eradication of the polyp
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to perform polypectomies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 1-RM lower body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SJ (Squat Jump) height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMJ (Countermovement Jump) height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chair rising performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: initial operating room performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: surgical confidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of community members intending to use EMS during a witnessed cardiac event
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients observed using EMS for chest pain
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: curative endoscopic resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: delayed bleeding rate
Endpoint domain: Adverse events/effects
Primary endpoint: perception of the 10‐year risk of myocardial infarction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Supine Systolic Blood Pressure (MSupSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Supine Diastolic Blood Pressure (MSupDBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative Abstinence Duration Proportion (CADP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rankin Scale score of 3 to 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum alanine aminotransferase activity (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Prothrombin time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Dysphagia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Concomitant use of gastrointestinal prescribed medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Risk of hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative VHI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Operative cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: unsupported handgrip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: pinch strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: feeding tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: biochemical profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of cautery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: left arm path length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak intraoperative blood glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequencies of severe hyperglycemia (BG≥180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequencies of early postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Respiratory rate (RR) during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean IgE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ragweed-induced nasal volume response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basophil FcepsilonRI expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Disappearance of AK lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in shoulder symptoms and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of renal function by day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Degree of independence in self-care and locomotion
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Perceived physical function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-recovery status
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Probability of being free of oral ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of being free of nodular lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean numbers of oral ulcers, nodular lesions, and papulopustular lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tobacco use documentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cholesterol testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of referrals to the screening stage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 1,5-AG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Myocardial lesion area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum hsCRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cancer-free survival
Endpoint domain: Mortality/survival
Primary endpoint: 2-year cumulative survival
Endpoint domain: Mortality/survival
Primary endpoint: rate of IOP failure at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed of Reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falls frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refilled prescriptions on time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Medication possession ratio (MPR)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of postpartum depression (PPD)
Endpoint domain: Adverse events/effects
Primary endpoint: sorbitol content in neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: myo-inositol content in neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fatal perioperative myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Non-fatal myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient attendance at treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: MVC improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General health score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Coronary Risk Ratio reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: P300 amplitude in the DAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: P100 amplitude in the DAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Performance in the SST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: sexual initiation
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: recent sex
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Pr-aCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-abdominal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical success defined as continued closure of treated veins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody levels for PCV7 antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of fever above 38.0 degrees C
Endpoint domain: Adverse events/effects
Primary endpoint: Number of visits for seroma
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time of drain removal to final seroma resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of head impacts during play
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of IL-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequencies of CD4(+)IL-9(+)T-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Endoscopically confirmed healing of reflux oesophagitis after 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Healing rates after 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rates of placental microbial isolation
Endpoint domain: Adverse events/effects
Primary endpoint: Completion of preventive therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median number of months of isoniazid dispensed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOM duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOM incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOM severity
Endpoint domain: Adverse events/effects
Primary endpoint: ITT (Intestinal Transit Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: eosinophilia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: asthma morbidity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of new visceral malignancy
Endpoint domain: Mortality/survival
Primary endpoint: Cancer-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: Withdrawal due to adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: ADHF events
Endpoint domain: Mortality/survival
Primary endpoint: Median operative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy in defining the Siewert type
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Independent living skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: incremental cost-effectiveness ratio (ICER) per grade 3-4 OM case prevented
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Nutrition risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cartilage repair assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade >or=2 musculoskeletal toxicity (arthralgia)
Endpoint domain: Adverse events/effects
Primary endpoint: Spatial ability (block design test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal fluency (Controlled Oral Word Association Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of full-thickness macular hole
Endpoint domain: Adverse events/effects
Primary endpoint: prevalence of persistent pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COPD knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hospitalisation for gastrointestinal infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Seroconversion of HAI antibodies to H5N2 virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion of HAI antibodies to H5N1 virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rise in SIgA antibodies after vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in urge UI episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate-severe dry mouth
Endpoint domain: Adverse events/effects
Primary endpoint: retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of reflux oesophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of H. pylori colonies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: E/e'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liquid stomach content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean time to 7-mm pupil size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to maintain 7-mm pupil size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assisted primary patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Symptomatic urinary tract infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Achievement of preoperative weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pressure-time integrals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean foot-to-floor contact durations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean peak pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: observer-rated sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increases in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: increases in heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: quadriceps muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean anal resting pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of fissure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myeloid engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet transfusion independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suppression of cutaneous reactivity to histamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 12-month mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: length of stay in acute hospital settings
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: length of stay in palliative hospital settings
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: adolescent dispositional curiosity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: relative VO2peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of severe symptomatic hypocalcemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of paracetamol administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aesthetic improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: parasitaemia prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: retention and utilization of nets
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neurological function improvement (NIHSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Daily living capabilities improvement (ADL Barthel index)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Shortening of hospitalization days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Plasma NE concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in S. mutans counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: KSS objective knee scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Double limb support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased functional connectivity of the hippocampus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visual Analogue Score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of intensive care unit stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: colonization of the respiratory tract with Pseudomonas aeruginosa
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MACE related to target SVG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MACE related to target SVG lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: median progression-free survival (mPFS)
Endpoint domain: Mortality/survival
Primary endpoint: objective response rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disease control rate (DCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acquisition of HIV-1 infection by 12 months
Endpoint domain: Mortality/survival
Primary endpoint: incidence of combined grade 3/4 neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness in eliminating CIN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ferritin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Carotid IMT regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Use of alpha-blockers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain after propofol infusion average score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of pain after propofol infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average withdrawal movements response score linked to rocuronium injection pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of withdrawal movements response linked to rocuronium injection pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal chest tube position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Risk of misplacement of chest tubes
Endpoint domain: Adverse events/effects